Innovista Health’s Post

We're inspired by industry leaders like DaVita's Jeff Giullian, MD MBA, who are leveraging value-based models to revolutionize kidney care. Currenly, DaVita has $5 billion at risk in value-based contracts and 80,000 patients benefiting from value-based programs. Their initatives mirror our commitment to: - Reducing care fragmentation - Enhancing the patient experience - Addressing social drivers of health - Balancing the benefits of technology with compassionate, human-centered care Dr. Giullian's emphasis on these points resonate deeply with our mission. At Innovista Health, we're committed to leveraging innovation while never losing sight of the personal, compassionate care people deserve. Check out Dr Giullian's interview in Healthcare Innovation: https://lnkd.in/exds_8xf #valuebasedcare #nephrology

DaVita CMO on the Impact of Value-Based Models on Kidney Care

DaVita CMO on the Impact of Value-Based Models on Kidney Care

hcinnovationgroup.com

To view or add a comment, sign in

Explore topics